I'm Michel Martin, and this is TELL ME MORE from NPR News.
Coming up, this is the month when we acknowledge the contributions of Asian-Americans and Pacific Islanders to the history and ongoing life of this country. We decided to observe it by speaking with people who have changed the game in their respective fields. Today, we are talking with Hikaru Nakamura. At the ripe old age of 24, he has already won the U.S. Championships twice and he's working on his third, as we speak. We'll have that conversation in just a few minutes.
That's how much President Obama campaign will receive from a fund-raising event last night at George Clooney's home. The New York Times reports the A-list, Hollywood crowd paid $40,000 a person, helping to set "a record for a presidential election fund-raiser."
In what could mark a watershed in the fight against HIV/AIDS, a panel of experts recommended that the Food and Drug Administration give a green light to a pill that can cut the risk of infections.
The daily pill, Truvada, made by Gilead Sciences, combines two medicines that inhibit the reproduction of HIV. It's already approved as a treatment for HIV, but its use could soon expand to include protection of uninfected people.